2012 has been a promising year for patients with bladder cancer. Published reports have challenged current knowledge in areas ranging from disease aetiology to second-line chemotherapy. However, advances in the care of this cancer lag behind those in many other malignancies, reflecting the low priority of bladder cancer to many research funders.
- Aidan P. Noon
- James W. F. Catto